Nyxoah SA (NYXH) Reiterated at Overweight by Cantor Fitzgerald on US Commercialization Mar 23, 2026 07:52AM
Nyxoah stock surges after FDA approves Genio system for sleep apnea Aug 11, 2025 09:13AM
Cantor Fitzgerald Reiterates Overweight Rating on Nyxoah SA (NYXH) Aug 11, 2025 07:00AM
Cantor Fitzgerald Reiterates Overweight Rating on Nyxoah SA (NYXH) May 19, 2025 06:44AM
Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer Mar 17, 2025 07:38AM


May 23, 2024 10:00AM Nyxoah (NYXH) Prices 5.37M Share Offering at $9.25/sh
May 23, 2024 09:59AM Nyxoah Announces Pricing of Offering
May 15, 2024 06:35AM Nyxoah SA (NYXH) PT Lowered to $17 at Cantor Fitzgerald
Apr 13, 2023 04:08PM Nyxoah (NYXH) Raises $3M via ATM
Apr 13, 2023 04:05PM Nyxoah Raises $3 Million from its At-the-Market Equity Offering
Dec 22, 2022 04:13PM Nyxoah (NYXH) Announces $200M At-the-Market Equity Offering Program
Dec 22, 2022 04:12PM Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program
Jul 11, 2022 08:35AM We Encourage Investors to Acquire Nyxoah SA (NYXH) Shares - Cantor Fitzgerald Bullish on Stock Following FDA Approval of ACCESS Trial
Jun 2, 2022 08:44AM Cantor Fitzgerald Reiterates Overweight Rating, $34 Price Target on Nyxoah SA (NYXH)
Jul 28, 2021 06:04AM UPDATE: Cantor Fitzgerald Starts Nyxoah SA (NYXH) at Overweight
Jul 8, 2021 04:30PM Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares
Jul 2, 2021 08:41AM Nyxoah SA (NYXH) Prices 2.835M Share IPO at $30/sh
Jul 2, 2021 08:40AM Nyxoah Announces Pricing of Nasdaq Public Offering
Jun 25, 2021 06:30AM Nyxoah Announces Launch of Proposed Public Offering in the United States
Jun 10, 2021 05:41PM Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States